Pharmacodynamics: mechanism of action
To understand how the drug works, it is necessary to examine its effect on bronchial secretion in detail. Ambroxolum has a complex effect on the respiratory system, which consists of several key components:
- Mucolytic effect: the drug directly alters the spatial structure of mucopolysaccharides that make up viscous sputum. The breakdown of these bonds leads to changes in the rheological properties of the secretion, making it more fluid.
- Mucokinetic action: the medicinal product increases the secretion of glycoproteins by glandular cells, which additionally normalizes the composition of the mucus.
- Activation of mucociliary clearance: the drug purposefully stimulates the motor activity of the bronchial ciliated epithelium. The cilia begin to beat more intensively, which, combined with sputum liquefaction, provides a pronounced expectorant effect and facilitates the discharge of secretions.
Effect on the pulmonary surfactant system
One of the most important pharmacological features of the drug is its interaction with endogenous surfactant—a special surface-active substance that lines the alveoli and prevents their collapse.
The mechanism of action in this aspect is bidirectional:
- Stimulation of production: the drug activates the synthesis of new surfactant in the lungs.
- Reduction of breakdown: the drug inhibits the degradation processes of the already existing surface-active substance.
It is precisely due to this property that the drug has found its specific application in pediatrics and neonatology. It is prescribed to premature and newborn infants for the treatment of respiratory distress syndrome, which is characterized by a critical shortage of their own surfactant.
Chemical structure and relationship with other drugs
When studying the chemical structure of expectorants, it is important to understand their classification. Unlike acetylcysteine, which is a derivative of the amino acid cysteine and exerts its effect through the presence of a free sulfhydryl SH-group, ambroxol has a completely different nature.
Ambroxol and its pharmacological precursor bromhexine share a similar chemical structure. Both of these compounds belong to the group of benzylamine derivatives. Their molecular structure contains specific bromine atoms as well as a characteristic cyclohexyl ring. It is this structural similarity that determines their close pharmacological relationship.
Pharmacokinetics, indications, and side effects
The drug is intended for oral administration. After ingestion, the onset of the therapeutic effect is registered as early as 30 minutes later. The duration of the clinical effect remains high for 10–12 hours.
Indications for use include a wide range of acute and chronic respiratory diseases:
- Bronchitis of various courses.
- Pneumonia.
- Bronchial asthma.
- Bronchiectasis.
Despite its high efficacy, therapy may be accompanied by adverse reactions. Side effects are predominantly localized in the gastrointestinal tract. Patients may report nausea, episodes of vomiting, and various intestinal disorders.
Briefly: answers to topical questions
Which respiratory diseases are indications for the use of ambroxol?
Indications for the use of ambroxol are acute and chronic respiratory diseases. These include:
- Bronchitis — acute and chronic.
- Pneumonia — including community-acquired.
- Bronchial asthma — with difficult sputum clearance.
- Bronchiectasis.
- COPD — during exacerbation with productive cough.
- Respiratory distress syndrome — in newborns and premature infants to stimulate surfactant synthesis.
What side effects does ambroxol cause?
Side effects of ambroxol predominantly manifest in the gastrointestinal tract:
- Nausea.
- Vomiting.
- Intestinal disorders.
What are the contraindications to prescribing ambroxol?
Contraindications to prescribing ambroxol are:
- Pregnancy, especially the 1st trimester.
- Breastfeeding.
- Combination with antitussives in wet cough with bronchial obstruction.
What are the main pharmacokinetic parameters of ambroxol?
The main pharmacokinetic parameters of ambroxol include the characteristics of its administration, onset rate, and duration of the therapeutic effect. These include:
- Route of administration — oral (the drug is taken by mouth, per os).
- Onset of action — therapeutic effect develops 30 minutes after administration.
- Duration of effect — mucolytic action lasts for 10–12 hours.
To easily remember the mechanism of action of the drug, use the three "S" rule: Structure (alters the structure of sputum mucopolysaccharides), Secretion (increases glycoprotein production), and Surfactant (stimulates its synthesis and inhibits breakdown).
Class and exam questions
What is the fundamental difference in the chemical structure of ambroxol and acetylcysteine?
Acetylcysteine is a derivative of the amino acid cysteine and contains a sulfhydryl SH-group. Ambroxol, on the other hand, is a benzylamine derivative containing bromine atoms and a cyclohexyl ring in its structure.
How does the drug affect mucociliary clearance?
The medicinal product directly stimulates the motor activity of the bronchial ciliated epithelium, which helps the cilia clear the liquefied secretion faster.
Why is ambroxol the drug of choice in neonatology for respiratory distress syndrome?
This is due to its unique ability to affect endogenous surfactant: the drug stimulates its production in the lungs of premature newborns while simultaneously reducing its breakdown.
How quickly does the effect onset after taking the drug and how long does it last?
Upon oral administration, the action begins after 30 minutes, and the therapeutic effect lasts for 10–12 hours.
What else to study on this topic
- Comparative pharmacodynamics of mucolytics: benzylamine derivatives versus cysteine derivatives.
- Physiology and biochemistry of pulmonary surfactant: mechanisms of synthesis and degradation.
- Pathogenesis of respiratory distress syndrome in premature newborns.
- The role of mucociliary clearance in airway protection during bronchitis.
- Changes in sputum rheological properties in bronchiectasis.
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Ambroxol" and 5,304 more subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section 'Drugs acting on respiratory system functions'
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.